Supplement guide · Fatigue and cognition

Rhodiola: Fatigue, Stress and Focus

📄 22 PubMed citations

Rhodiola rosea is an Arctic root sold for stress and mental fatigue. A handful of small trials of one Swedish extract carry most of the evidence, and many jars on the market contain a different plant.

🔬 Rhodiola is sold as an adaptogen for stress, burnout and focus. When we sorted the PubMed record by study design, the placebo-controlled human evidence came down to a few small trials, most of them testing one extract, SHR-5, on fatigue during night shifts, exams, military duty and burnout. Two systematic reviews rate that evidence as promising but flawed. The stress and burnout studies of a second extract, WS 1375, had no placebo group, and the only US trial against an antidepressant found rhodiola did no better than placebo. This page lists each finding with its study type, then covers product quality, which several labs found to be poor.
161
Military cadets in the largest SHR-5 mental-fatigue trial
11
Trials in a 2012 fatigue review, all at high or unclear risk of bias
1 in 5
Products sold as Rhodiola rosea that had no rosavin, of about 40 tested
A narrow dirt trail winding along a green mountainside with forested valley and snow-dusted peaks beneath a blue sky
Photo: Forest Service Pacific Northwest Region · Public Domain · source

Build your own printable peptide tracker

A personalized injection log, weekly dosing schedule and dated calendar: your compounds filled in, ready to print. Free to build and preview; $5/month to unlock printing.

Stacking compounds? Check interactions first →

Build your tracker →

What Is Rhodiola and How Might It Work?

🌱
A cold-climate root

Rhodiola rosea, also called golden root or arctic root, is registered in the UK as a traditional herbal medicine for stress-induced fatigue, exhaustion and anxiety. Rosavin is the marker that separates it from related Rhodiola species, while salidroside also occurs in other species (Rhodiola product authenticity study, PMID 26626192). About 140 compounds have been isolated from the root and rhizome (rosenroot review, PMID 20378318).

⏱️
The morning cortisol signal

In the stress-related fatigue trial, the change in salivary cortisol response to awakening differed between the SHR-5 group and the placebo group after 28 days (stress-related fatigue RCT, PMID 19016404). A 2010 review lists proposed links to stress-system proteins such as Hsp70, drawn from cell and animal work (rosenroot review, PMID 20378318).

🧫
Gene activity in brain cells

In a human neuroglia cell line, SHR-5 extract changed the expression of 1,062 genes, and salidroside, triandrin and tyrosol each changed a similar number. The authors concluded that several compounds contribute to the effect, not one active ingredient (neuroglial cell gene study, PMID 25172797). This is test-tube work.

🧠
Synaptic plasticity after one dose

In 28 healthy volunteers, a single 500 mg dose of rhodiola extract prevented the long-term-depression-like drop in motor responses that cathodal brain stimulation normally causes, and did not change cortical excitability (human neuroplasticity study, PMID 30477830).

What the Data Shows

Burnout with fatigue, 576 mg a day
60 adults, 28 days: SHR-5 beat placebo on the Pines burnout scale and on attention errors and variability; both groups improved on several measures, a placebo effect (stress-related fatigue RCT; PMID 19016404)
Beat placebo
Anti-fatigue index, single dose
161 cadets: 1.0385 on 2 capsules and 1.0195 on 3 capsules vs 0.9046 on placebo (p < 0.001); the higher dose was no better (SHR-5 cadet RCT; PMID 12725561)
1.04 vs 0.90
Depression score drop, 12 weeks
57 adults with major depression: HAM-D fell 5.1 points on rhodiola, 4.6 on placebo and 8.2 on sertraline; no group differed significantly (p = 0.79) (rhodiola vs sertraline RCT; PMID 25837277)
5.1 vs 4.6
Side effects reported, same trial
30.0% on rhodiola vs 63.2% on sertraline and 16.7% on placebo (p = 0.012) (rhodiola vs sertraline RCT; PMID 25837277)
30% vs 63%
Endurance (VO2max), pooled trials
A 2025 meta-analysis of 26 RCTs found a small gain (effect size 0.32 across 11 studies; PMID 41080184); a 2026 meta-analysis of 9 RCTs found no significant effect (p = 0.30; PMID 42908635)
Mixed

Daily Dosing Schedule

TimeCompounds
Stress-related fatigue, burnout576 mg a day of SHR-5 extract, taken as four tablets, for 28 days (stress-related fatigue RCT, PMID 19016404).
Mild to moderate depression340 or 680 mg a day of SHR-5 for 6 weeks. Both doses improved overall depression scores and the placebo group did not (SHR-5 depression trial, PMID 17990195).
Life stress and prolonged fatigue200 mg of WS 1375 extract twice a day for 4 to 8 weeks, in two open-label studies with no placebo group (life-stress study, PMID 22228617; prolonged fatigue study, PMID 28219059).
Mild anxiety200 mg before breakfast and 200 mg before lunch for 14 days, compared with no treatment rather than a placebo (Vitano anxiety trial, PMID 26502953).
Before demanding mental workA single dose of 2 or 3 SHR-5 capsules in cadets. The 50% higher dose added nothing (SHR-5 cadet RCT, PMID 12725561).

Key Takeaways

What We Know
  • In 60 adults with stress-related fatigue, 576 mg a day of SHR-5 for 28 days beat placebo on a burnout scale and on several attention measures, though both groups improved (PMID 19016404).
  • In 161 cadets doing mental work under fatigue, a single dose of SHR-5 raised an anti-fatigue index to 1.0385 vs 0.9046 on placebo, and a 50% higher dose was no better (PMID 12725561).
  • Night-duty physicians (56) scored better on mental-fatigue tests on low-dose SHR-5 than on placebo, though only in the first two-week period of a crossover (PMID 11081987), and students during exams improved on mental fatigue and physical fitness vs placebo (PMID 10839209).
  • A 2011 systematic review found 11 placebo-controlled trials, most of moderate or good quality, with only a few mild adverse events reported (PMID 21036578).
  • In the sertraline comparison trial, 30.0% of people on rhodiola reported adverse events vs 63.2% on sertraline (PMID 25837277).
  • Product quality varies widely: about one fifth of products sold as Rhodiola rosea contained no rosavin (PMID 26626192), and labelled salidroside and rosavin amounts were confirmed in fewer than a quarter of products in a second analysis (PMID 32311178).
What We Don't Know
  • Whether the fatigue results replicate. A 2012 review rated every included trial at high or unclear risk of bias (PMID 22643043), and a 2011 review pointed to a lack of independent replications (PMID 21036578).
  • Whether rhodiola treats depression. A 6-week SHR-5 trial reported gains at 340 and 680 mg (PMID 17990195), but in a 12-week trial against sertraline rhodiola did not differ from placebo (PMID 25837277).
  • Whether the stress and burnout gains are a drug effect. The WS 1375 studies were single-arm and open-label (PMID 22228617, PMID 28219059, PMID 28367055), one with a co-author listing a Dr Willmar Schwabe affiliation (PMID 28367055), and the anxiety trial used a no-treatment control (PMID 26502953).
  • Whether it sharpens thinking in healthy people. The anxiety trial found no relevant difference in cognitive tests (PMID 26502953); a 2025 trial in lifters reported Stroop gains measured against a no-capsule condition (PMID 41374026).
  • Whether it helps endurance. Two meta-analyses disagree on VO2max (PMID 41080184, PMID 42908635), and the 2026 analysis found no protection against acute mountain sickness (PMID 42908635).
  • How it interacts with medicines. Six commercial products inhibited the drug-metabolizing enzyme CYP3A4 in the test tube (PMID 27572116), while purified salidroside showed no interaction risk in a lab study whose authors hold stock in its maker (PMID 37686755). The trials cited here ran 12 weeks at most (PMID 25837277, PMID 28367055).

Frequently Asked Questions

Does rhodiola help with focus or mental fatigue?

Under stress or fatigue, several small trials say yes. SHR-5 beat placebo on attention measures in people with stress-related fatigue (stress-related fatigue trial, PMID 19016404) and on an anti-fatigue index in cadets (cadet trial, PMID 12725561), and night-duty physicians did better on mental-fatigue tests during the first two-week period of a crossover trial (night-duty physicians trial, PMID 11081987). In mildly anxious adults it made no difference to cognitive tests (anxiety trial, PMID 26502953).

Does rhodiola help with stress and anxiety?

The supporting studies lack a placebo arm. In 80 mildly anxious adults, 200 mg twice daily for 14 days reduced self-reported anxiety, stress and anger compared with no treatment (Vitano anxiety trial, PMID 26502953). In 101 adults with life-stress symptoms, 200 mg twice daily improved stress scores within 3 days in a single-arm study (WS 1375 life-stress study, PMID 22228617).

Is rhodiola an antidepressant?

The evidence conflicts. In 89 patients with mild to moderate depression, 340 or 680 mg a day of SHR-5 for 6 weeks improved depression scores while placebo did not (SHR-5 depression trial, PMID 17990195). In a 12-week US trial, rhodiola cut depression scores by 5.1 points vs 4.6 on placebo and 8.2 on sertraline, with no significant differences between groups (rhodiola vs sertraline trial, PMID 25837277).

How much rhodiola do studies use?

Most trials used 340 to 680 mg a day of an extract. The burnout trial gave 576 mg of SHR-5 daily for 28 days (PMID 19016404), the depression trial 340 or 680 mg (PMID 17990195), and the WS 1375 studies 200 mg twice a day (PMID 22228617, PMID 28219059). A 2025 meta-analysis of endurance trials saw larger VO2max gains above 600 mg a day (endurance meta-analysis, PMID 41080184).

How do I know a rhodiola product is real?

Check the label for rosavin, not only salidroside. In about 40 products tested in the UK, roughly one fifth labelled Rhodiola rosea had no rosavin, the marker of the true species, and many others appeared to contain other Rhodiola species (Rhodiola product authenticity study, PMID 26626192). Of six commercial products tested in Norway, one contained no rosavin, rosarin or rosin at all (commercial product CYP study, PMID 27572116).

Does rhodiola interact with medications?

Possibly. Commercial rhodiola products inhibited CYP3A4, CYP2D6 and CYP1A2, liver enzymes that clear many drugs, in test-tube work, and the authors note one product had already been shown to inhibit these enzymes in people (commercial product CYP study, PMID 27572116). Ask a pharmacist or clinician before combining it with prescription medicines.

Peer-Reviewed References

Source 1
A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract shr-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue
Planta Med · 2009
PMID: 19016404
Source 2
Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression
Nord J Psychiatry · 2007
PMID: 17990195
Source 3
Rhodiola rosea in stress induced fatigue--a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty
Phytomedicine · 2000
PMID: 11081987
Source 4
A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen
Phytomedicine · 2000
PMID: 10839209
Source 5
A randomized trial of two different doses of a SHR-5 Rhodiola rosea extract versus placebo and control of capacity for mental work
Phytomedicine · 2003
PMID: 12725561
Source 6
Rhodiola rosea for physical and mental fatigue: a systematic review
BMC Complement Altern Med · 2012
PMID: 22643043
Source 7
The effectiveness and efficacy of Rhodiola rosea L.: a systematic review of randomized clinical trials
Phytomedicine · 2011
PMID: 21036578
Source 8
Rhodiola rosea in Subjects with Prolonged or Chronic Fatigue Symptoms: Results of an Open-Label Clinical Trial
Complement Med Res · 2017
PMID: 28219059
Source 9
Therapeutic effects and safety of Rhodiola rosea extract WS® 1375 in subjects with life-stress symptoms--results of an open-label study
Phytother Res · 2012
PMID: 22228617
Source 10
The Effects of Rhodiola rosea L. Extract on Anxiety, Stress, Cognition and Other Mood Symptoms
Phytother Res · 2015
PMID: 26502953
Source 11
Rhodiola rosea versus sertraline for major depressive disorder: A randomized placebo-controlled trial
Phytomedicine · 2015
PMID: 25837277
Source 12
The authenticity and quality of Rhodiola rosea products
Phytomedicine · 2016
PMID: 26626192
Source 13
Antioxidant but not ergogenic or altitude-protective: a meta-analysis of Rhodiola species in healthy adults
Front Physiol · 2026
PMID: 42908635
Source 14
The effect of Rhodiola rosea supplementation on endurance performance and related biomarkers: a systematic review and meta-analysis
Front Nutr · 2025
PMID: 41080184
Source 15
Multicenter, open-label, exploratory clinical trial with Rhodiola rosea extract in patients suffering from burnout symptoms
Neuropsychiatr Dis Treat · 2017
PMID: 28367055
Source 16
Authenticity and quality evaluation of different Rhodiola species and commercial products based on NMR-spectroscopy and HPLC
Phytochem Anal · 2020
PMID: 32311178
Source 17
Dose-Response Effects of Short-Term Rhodiola rosea (Golden Root Extract) Supplementation on Anaerobic Exercise Performance and Cognitive Function in Resistance-Trained Athletes: A Randomized, Crossover, Double-Blind, and Placebo-Controlled Study
Nutrients · 2025
PMID: 41374026
Source 18
Mechanism of action of Rhodiola, salidroside, tyrosol and triandrin in isolated neuroglial cells: an interactive pathway analysis of the downstream effects using RNA microarray data
Phytomedicine · 2014
PMID: 25172797
Source 19
Exploring the effect of adaptogenic Rhodiola Rosea extract on neuroplasticity in humans
Complement Ther Med · 2018
PMID: 30477830
Source 20
In vitro inhibition of cytochrome P-450 activities and quantification of constituents in a selection of commercial Rhodiola rosea products
Pharm Biol · 2016
PMID: 27572116
Source 21
In Vitro Evaluation of the Potential for Drug Interactions by Salidroside
Nutrients · 2023
PMID: 37686755
Source 22
Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy
Phytomedicine · 2010
PMID: 20378318
Ebook
The Complete Peptide Protocol Guide

67-page guide: protocols, dosing, sourcing. Everything in one place.

Get the guide: $19 (normally $29) → The Peptide Buyer’s Playbook ($19) All ebooks & guides →
Disclaimer

Educational purposes only. Not medical advice.

Rhodiola is sold in the US as a dietary supplement, not an FDA-approved drug. Talk to a clinician before using it if you are pregnant, take prescription medicines, or are being treated for any condition.

📘

Get the Free 2026 Peptide Protocol Stack

Twelve compounds across four pillars: metabolic, tissue repair, longevity, cognitive. Citations included, formatted to print. Sent straight to your inbox.